日本語 
Eisai Co., Ltd. and Nuvation Bio Inc. have pushed taletrectinib into the next stage in Europe. The European Medicines Agency has validated the application. That basically means the file is…
Dr.JOY Introduces Hospital DX Implementation Service
Dr.JOY Inc., with the mission of "giving all medical professionals the next…
AI-Assisted Preventive Care in Japan: How Data Is Shifting Healthcare from Treatment to Prediction
Japan is running a live experiment the rest of the world is…
How ChatGPT Health Is Reshaping Personal Health Management
OpenAI’s launch of ChatGPT Health is not about entering hospitals or challenging…
AMI Co., Ltd. receives regulatory approval for ‘Digital Biomarker DNP-AS’
AMI Inc., which is working to make medical innovation faster through AI…
AMI Receives Regulatory Approval for Digital Biomarker DNP-AS
AMI Inc., which aims to realize rapid medical innovation through the research…
EPARK Dental Brings Patient Communication onto LINE
Empower Healthcare has launched new LINE-based services under EPARK Dental, aiming to…
CureApp Introduces DTx-BASE to Tackle the Hard Parts of Digital Therapeutics
CureApp has launched a new business called DTx-BASE, aimed at helping companies…
CI Partners Secures ¥400 Million to Scale Disability Support Nationwide
CI Partners has raised ¥400 million in a Series B round, completed…
English